Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness

NCT05004818 is registered in ClinicalTrials.gov with Medical Corps, Israel Defense Force as lead sponsor.

NCT NCT05004818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05004818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
Lead sponsor
Medical Corps, Israel Defense Force
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2016
Completion date
July 1, 2019
Enrollment
54 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

habituation, motion sickness, seasickness, vestibular time constant